Clinical trial
Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
NCT02652091 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 5, 2016
- Completion date
- September 13, 2017
- Enrollment
- 146 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.